HDAC6 inhibitor
Search results
Scope
Date
~
-
Bio & Pharma
HLB submits new drug application to FDA for Rivoceranib liver cancer drug
HLB Co. announced on May 17 that it has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for the approval of Rivo...
May 19, 2023 (Gmt+09:00)
1
Latest News
- 1 AI plagiarism detection startup muhayu eyes IPO in 2026
- 2 Lotte Biologics targets $1.1 bn in sales with new bio plant
- 3 Korea’s top resort operator Sono buys LCC T’way stake
- 4 DN Solutions to build plant, R&D center in India
- 5 This Song Is Catchy and Going Viral. It’s Also North Korean Propaganda.